Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Xact Bear XACTBEAR Jan 22, 2020 42.73 +1.18   
 Xact Bear 2 XACTBEAR2 Jan 22, 2020 31.57 +1.45   
 Xact Bull XACTBULL Jan 22, 2020 465.55 -1.21   
 Xact Bull 2 XACTBULL2 Jan 22, 2020 940.50 -1.54   
 XACT Högutdelande XACTHDIV Jan 22, 2020 133.14 -0.12   
 Xact OMXS30 XACTOMXS30 Jan 22, 2020 227.20 -0.79   
 XANO Industri B XANOB Jan 22, 2020 112.00 -0.89   
 Xavitech B XAVIB Jan 22, 2020 1.16 -4.92   
 Xbrane Biopharma XBRANE Jan 22, 2020 40.00 +3.09   
 Xintela XINT Jan 22, 2020 4.44 +0.91   
 XMReality XMR Jan 22, 2020 3.20 -3.32   
 Xspray Pharma XSPRAY Jan 22, 2020 80.00 -0.25   
 Xvivo Perfusion XVIVO Jan 22, 2020 187.80 -0.11   
 XXL XXLO Jan 22, 2020 13.06 0.00   
 Yara International YARO Jan 22, 2020 348.80 +0.61   
 Zaplox ZAPLOX Jan 22, 2020 2.45 +23.74   
 Zenergy B ZENZIPB Jan 22, 2020 0.45 -1.75   
 Zenicor ZENI Jan 22, 2020 13.80 +2.99   
 ZetaDisplay ZETA Jan 22, 2020 22.20 -1.33   
 Ziccum ZICC Jan 22, 2020 14.10 -2.76   
 ZignSec ZIGN Jan 22, 2020 9.34 0.00   
 Zinzino B ZZB Jan 22, 2020 31.20 +0.97   
 Zoomability ZOOM Jan 22, 2020 4.92 -3.15   
 Zordix B ZORDIXB Jan 22, 2020 9.82 +6.74   
 Zutec ZUTEC Jan 22, 2020 1.10 +4.27   
 ÅF Pöyry B AFB Jan 22, 2020 248.80 -0.08   
 Öresund ORES Jan 22, 2020 129.00 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK